Supplementary Online Content

Size: px
Start display at page:

Download "Supplementary Online Content"

Transcription

1 Supplementary Online Content Shurraw S, Hemmelgarn B, Lin M, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;303(21): efigure. Smoothed cubic spline of the relation between baseline A1C and index egfr. etable 1. Characteristics of patients included in and excluded from the study. etable 2. Adjusted risk of adverse outcomes among people with stage 3 CKD, using A1C as a time-varying covariate. etable 3. Adjusted risk of adverse outcomes among people with stage 4 CKD, using A1C as a time-varying covariate. This supplementary material has been provided by the authors to give readers additional information about their work.

2 efigure 1: Smoothed cubic spline of the relation between baseline A1C and index egfr The red line represents the smoothed cubic spline of mean A1C, and blue lines represent the 95% confidence interval.

3 etable 1: Characteristics of patients included in and excluded from the study With A1C measurement n=23296 Without A1C measurement n=8041 P Age, mean (SD), y 71.7 (11.4) 74.5 (11.8) <.0001 Female (55) 4651 (58) <.0001 Socioeconomic status* Assistance Normal Subsidy 775 (3) 6918 (30) (67) 252 (3) 1848 (23) 5941 (74) <.0001 Index egfr 46.8(10.5) 46.3 (10.6) < (9) 755 (9) (91) 7286 (91) Comorbidities Cancer 2449 (11) 1201 (15) <.0001 Cardiovascular disease 2524 (11) 1283 (16) <.0001 Heart failure 4516 (19) 2241 (28) <.0001 COPD 5493 (24) 2497 (31) <.0001 Dementia 1544 (7) 1001 (12) <.0001 HIV 4 (0.02) 1 (0.01) 0.999* Metastatic cancer 312 (1) 251 (3) <.0001 Myocardial infarction 2887 (12) 1316 (16) <.0001 Mild liver disease 418 (2) 215 (3) <.0001 Moderate/severe liver disease 104 (0.5) 79 (1) <.0001 Paraplegia 355 (2) 196 (2) <.0001 Peptic ulcer disease 954 (4) 454 (6) <.0001 Peripheral vascular disease 2069 (9) 965 (12) <.0001 Rheumatological disease 618 (3) 307 (4) <.0001 Income ** Below Poverty Line 2175 (9) 732 (9) <.0001 Between poverty line and Alberta (54) 4533 (57) median income Higher than median 8419 (36) 2684 (34) Values are n(%) or mean (SD) as appropriate. *Exact test *Socioeconomic status: Assistance refers to participants with health insurance premium paid under a program sponsored by Alberta Employment, Immigration and Industry. Subsidy refers to participants who pay less than the full premium or no premium to Alberta Health and Wellness, or in the premium is subsidized though a Government Sponsored Program. Normal refers to all other participants. ** median income was unavailable for 265 participants. The Alberta median individual employment income was $29,500/y in The poverty line is $14,914/y for rural, $18,659/y for urban (except Calgary and Edmonton), and $21,666/y for Calgary and Edmonton.

4 etable 2: Adjusted risk of adverse outcomes among people with stage 3 CKD, using A1C as a time-varying covariate A1C < >9.0 All-cause mortality Adjusted HR (95% CI) (1.07, 1.25) 1.38 (1.25, 1.51) First episode of all-cause hospitalization Adjusted HR (95% CI) (1.01, 1.11) 1.29 (1.23, 1.36) Myocardial infarction Adjusted HR (95% CI) (1.14, 1.49) 1.88 (1.62, 2.19) Stroke Adjusted HR (95% CI) (0.93, 1.27) 1.71 (1.42, 2.06) Heart failure Adjusted HR (95% CI) (1.16, 1.46) 1.58 (1.40, 1.80) ESRD Adjusted HR (95% CI) (0.90, 1.98) 2.03 (1.39, 2.95) Sustained doubling of serum creatinine* Adjusted HR (95% CI) (1.09, 1.44) 1.53 (1.32, 1.76) ESRD, end-stage renal disease. *Doubling of serum creatinine could not be assessed for 330 pts because their creatinine was measured only at index date. Models were adjusted for age, gender, index egfr, individual health insurance premium level, median neighborhood income, comorbidity and residence location. All-cause

5 etable 3: Adjusted risk of adverse outcomes among people with stage 4 CKD, using A1C as a time-varying covariate A1C < >9.0 All-cause mortality Adjusted HR (95% CI) (0.93, 1.28) 1.27 (1.04, 1.55) P for trend < First episode of all-cause hospitalization Adjusted HR (95% CI) (0.93, 1.19) 1.05 (0.92, 1.20) Myocardial infarction Adjusted HR (95% CI) (0.90, 1.91) 1.85 (1.24, 2.75) Stroke Adjusted HR (95% CI) (0.66, 1.57) 1.69 (1.04, 2.74) Heart failure Adjusted HR (95% CI) (0.93, 1.50) 1.11 (0.83, 1.49) ESRD Adjusted HR (95% CI) (0.88, 1.50) 1.38 (1.05, 1.81) Sustained doubling of serum creatinine* Adjusted HR (95% CI) (0.67, 1.13) 1.63 (1.25, 2.11) ESRD, end-stage renal disease. *Doubling of serum creatinine could not be assessed for 19 pts because their creatinine was measured only at index date. Models were adjusted for age, gender, index egfr, individual health insurance premium level, median neighborhood income, comorbidity and residence location

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content James MT, Neesh P, Hemmelgarn BR, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA. doi:10.1001/jama.2017.16326

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Gomes T, Redelmeier DA, Juurlink DN, et al. Opiod dose and risk of road trauma in Canada: a populationbased study. JAMA Intern Med. Published online January 14, 2013. doi:10.1001/2013.jamainternmed.733.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Gershengorn HB, Scales DC, Kramer A, Wunsch H. Association between overnight extubations and outcomes in the intensive care unit. JAMA Intern Med. Published online September

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Steinhubl SR, Waalen J, Edwards AM, et al. Effect of a home-based wearable continuous electrocardiographic monitoring patch on detection of undiagnosed atrial fibrillation

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the

More information

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX

More information

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES UNIVERSITY OF CALGARY Quality of care and outcomes for First Nations People and non-first Nations People with diabetes mellitus by Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL

More information

Short-term change in kidney function and risk of end-stage renal disease

Short-term change in kidney function and risk of end-stage renal disease Nephrol Dial Transplant (2012) 27: 3835 3843 doi: 10.1093/ndt/gfs263 Advance Access publication 3 July 2012 Short-term change in kidney function and risk of end-stage renal disease Tanvir Chowdhury Turin

More information

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality clinical investigation http://www.kidney-international.org & 2013 International Society of Nephrology see commentary on page 550 Change in the estimated glomerular filtration rate over time and risk of

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney

More information

Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries

Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries Victoria L. Tseng, MD, Fei Yu, PhD, Flora Lum, MD, Anne L. Coleman, MD, PhD JAMA. 2012;308(5):493-501 Background Visual impairment

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital

More information

Appendix Identification of Study Cohorts

Appendix Identification of Study Cohorts Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med. 2012;172(2):127-132.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lin Y-S, Chen Y-L, Chen T-H, et al. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA 2 DS 2 -VASc Score. JAMA Netw

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Prepared for: American Hospital Association April 4, 2019 Berna Demiralp,

More information

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes. SUPPLEMENTAL MATERIAL Supplemental Table 1. Standardized Serum Creatinine Measurements Supplemental Table 2. List of ICD 9 and ICD 10 Billing Codes Supplemental Table 3. Sensitivity Analyses with Additional

More information

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

Definitions of chronic conditions used to define the number of serious comorbidities in the study. Supplementary Table 1 Definitions of chronic conditions used to define the number of serious comorbidities in the study. Comorbidity ICD-9 Code Description CAD/MI 410.x Acute myocardial infarction 411.x

More information

R. G. Weaver 1, B. R. Hemmelgarn 1,2, D. M. Rabi 1,2, P. M. Sargious 1, A. L. Edwards 1, B. J. Manns 1,2, M. Tonelli 3 and M. T. James 1,2.

R. G. Weaver 1, B. R. Hemmelgarn 1,2, D. M. Rabi 1,2, P. M. Sargious 1, A. L. Edwards 1, B. J. Manns 1,2, M. Tonelli 3 and M. T. James 1,2. Short Report: Educational and Psychological Issues Association between participation in a brief diabetes education programme and glycaemic control in adults with newly diagnosed diabetes R. G. Weaver 1,

More information

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia Supplementary Table S1 International Classification of Disease 10 (ICD-10) codes Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care I48 AF

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Berkowitz SA, Krumme AA, Avorn J, et al. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study. JAMA

More information

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1* Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pincus D, Ravi B, Wasserstein D. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. doi: 10.1001/jama.2017.17606 eappendix

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older

More information

Person-years; number of study participants (number of cases) HR (95% CI) P for trend

Person-years; number of study participants (number of cases) HR (95% CI) P for trend Table S1: Spearman rank correlation coefficients for cumulative factor score means of dietary and nutrient patterns among adults 18 years and above, the China Health and Nutrition Survey by age and sex

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Saloner B, Levin J, Chang H-Y, Jones C, Alexander GC. Changes in buprenorphinenaloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion.

More information

532.6 (chronic or unspecified duodenal

532.6 (chronic or unspecified duodenal Supplementary table 1: ICD-9 and ICD-10 codes used for the identification of major bleeding and endoscopy Bleeding episode type ICD-9 codes ICD-10 codes Intracranial 430 (Subarachnoid), 431 (intracerebral),

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GYH. Assessment of the CHA 2 DS 2 -VASc score in predicting ischemic stroke, thromboembolism, and death

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Khera R, Dharmarajan K, Wang Y, et al. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Swaminathan S, Sommers BD,Thorsness R, Mehrotra R, Lee Y, Trivedi AN. Association of Medicaid expansion with 1-year mortality among patients with end-stage renal disease. JAMA.

More information

Quality of Care in Early Stage Chronic Kidney Disease

Quality of Care in Early Stage Chronic Kidney Disease Quality of Care in Early Stage Chronic Kidney Disease 2012 2013 Supplementary Report to the 2015 Alberta Annual Kidney Care Report Kidney Health Strategic Clinical Network December 22, 2015 For more information

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Wolters FJ, Li L, Gutnikov SA, Mehta Z, Rothwell PM. Medical attention seeking after transient ischemic attack and minor stroke in relation to the UK Face, Arm, Speech, Time

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patientlevel data. Published online

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA

More information

Zhao Y Y et al. Ann Intern Med 2012;156:

Zhao Y Y et al. Ann Intern Med 2012;156: Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled

More information

Nephrology referral - Does my patient need it? Disclosure

Nephrology referral - Does my patient need it? Disclosure Nephrology referral - Does my patient need it? Sophia Chou, MD MSc March 10, 2018 Faculty: Sophia Chou Disclosure Relationships with commercial interest: None Potential conflict of interest: None 1 Objectives

More information

Treatment disparities for patients diagnosed with metastatic bladder cancer in California

Treatment disparities for patients diagnosed with metastatic bladder cancer in California Treatment disparities for patients diagnosed with metastatic bladder cancer in California Rosemary D. Cress, Dr. PH, Amy Klapheke, MPH Public Health Institute Cancer Registry of Greater California Introduction

More information

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24. NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2013 June 24; 173(12): 1150 1151. doi:10.1001/jamainternmed.2013.910. SSRI Use, Depression and Long-Term Outcomes

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

Health and Wellness Alberta Health Care Insurance Plan Statistical Supplement 2006/2007

Health and Wellness Alberta Health Care Insurance Plan Statistical Supplement 2006/2007 Health and Wellness Alberta Health Care Insurance Plan Statistical Supplement /2007 For further information For additional copies of the Statistical Supplement contact: Alberta Health and Wellness Communications

More information

Supplementary Digital Content Section A Procedural codes to define study population

Supplementary Digital Content Section A Procedural codes to define study population Supplementary Digital Content Section A Procedural codes to define study population Procedure CCI codes ORTHOPEDIC Total hip replacement 1.VA.53.LA-PN ; 1.VA.53.PN-PN Total knee replacement 1.VG.53 VASCULAR

More information

Disparities in Transplantation Caution: Life is not fair.

Disparities in Transplantation Caution: Life is not fair. Disparities in Transplantation Caution: Life is not fair. Tuesday October 30 th 2018 Caroline Rochon, MD, FACS Surgical Director, Kidney Transplant Program Hartford Hospital, Connecticut Outline Differences

More information

The Link Between Acute and Chronic Kidney Disease. John Arthur, MD, PhD

The Link Between Acute and Chronic Kidney Disease. John Arthur, MD, PhD The Link Between Acute and Chronic Kidney Disease John Arthur, MD, PhD Conventional Dogma Conventional dogma was that if a patient survived and recovered from AKI, he was unlikely to have long-term sequela.

More information

Effect of SGLT-2 Inhibitors on the Heart. Robert Zimmerman MD Vice Chairman Endocrinology Director Diabetes Center Cleveland Clinic

Effect of SGLT-2 Inhibitors on the Heart. Robert Zimmerman MD Vice Chairman Endocrinology Director Diabetes Center Cleveland Clinic Effect of SGLT-2 Inhibitors on the Heart Robert Zimmerman MD Vice Chairman Endocrinology Director Diabetes Center Cleveland Clinic Disclosures Speaker - Johnson and Johnson - Merck Research - Merck - Novo

More information

University of Bristol - Explore Bristol Research

University of Bristol - Explore Bristol Research Hunt, L., Ben-Shlomo, Y., Whitehouse, M., Porter, M., & Blom, A. (2017). The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following

More information

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Netw Open. 2018;1(4):e181100.

More information

Diabetes & the Medicare Population: Idaho

Diabetes & the Medicare Population: Idaho Diabetes & the Medicare Population: Introduction to the Report Diabetes has a considerable impact on the nation s healthcare system and on individuals living with the condition. This report is intended

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lin H-C, Stein JD, Nan B, et al. Association of geroprotective effects of metformin and risk of open-angle glaucoma in persons with diabetes mellitus. JAMA Ophthalmol. Published

More information

ENDPOINTS FOR AKI STUDIES

ENDPOINTS FOR AKI STUDIES ENDPOINTS FOR AKI STUDIES Raymond Vanholder, University Hospital, Ghent, Belgium SUMMARY! AKI as an endpoint! Endpoints for studies in AKI 2 AKI AS AN ENDPOINT BEFORE RIFLE THE LIST OF DEFINITIONS WAS

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

CKD Screening in Developing Countries. The case of Jalisco, Mexico.

CKD Screening in Developing Countries. The case of Jalisco, Mexico. CKD Screening in Developing Countries. The case of Jalisco, Mexico. Hospital Civil de Guadalajara. Hospitales Civiles de Guadalajara Foundation University of Alberta, Edmonton, CA e-mail: ggarcia1952@gmail.com

More information

Incorporating External Data into Existing Longitudinal Studies

Incorporating External Data into Existing Longitudinal Studies Incorporating External Data into Existing Longitudinal Studies Public Workshop: Addressing Inadequate Information on Important Health Factors in Pharmacoepidemiology Studies Relying on Healthcare Databases

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Drury KE, Schaeffer M, Silverberg JI. Association between atopic disease and anemia in US children. JAMA Pediatr. Published online vember 30, 2015. doi:10.1001/jamapediatrics.2015.3065.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Irish AB, Viecelli AK, Hawley CM, et al; for the Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Basaria S, Harman SM, Travison TG, et al. The effects of testosterone administration for three years on subclinical atherosclerosis progression in older men with low or low

More information

AHA Clinical Science Special Report: November 10, 2015

AHA Clinical Science Special Report: November 10, 2015 www.canheart.ca High-density lipoprotein cholesterol and cause-specific mortality: A population-based study of more than 630,000 individuals without prior cardiovascular conditions Dennis T. Ko, MD, MSc;

More information

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5). Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schmidt B, Whyte RK, Asztalos EV, et al; for the Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.8266

More information

Balancing Glycemic Overtreatment and Undertreatment for Seniors: An Out of Range (OOR) Population Health Safety Measure

Balancing Glycemic Overtreatment and Undertreatment for Seniors: An Out of Range (OOR) Population Health Safety Measure Balancing Glycemic Overtreatment and Undertreatment for Seniors: An Out of Range (OOR) Population Health Safety Measure Leonard Pogach, 1,2 Orysya Soroka, 1 Chin Lin Tseng, 1,2 Miriam Maney, 1 and David

More information

Chapter 2: Pharmacological cholesterol-lowering treatment in adults Kidney International Supplements (2013) 3, ; doi: /kisup.2013.

Chapter 2: Pharmacological cholesterol-lowering treatment in adults Kidney International Supplements (2013) 3, ; doi: /kisup.2013. http://www.kidney-international.org chapter & 3 KDIGO Chapter : Pharmacological cholesterol-lowering treatment in adults Kidney International Supplements (3) 3, 7 79; doi:.38/kisup.3.34 INTRODUCTION Therapeutic

More information

Research in Real Life. Real Life Effectiveness of Aclidinium Bromide. Version Date: 26 September 2013

Research in Real Life. Real Life Effectiveness of Aclidinium Bromide. Version Date: 26 September 2013 Research in Real Life Real Life Effectiveness of Aclidinium Bromide Version Date: 26 September 2013 Project for Almirall Real-life effectiveness evaluation of the long-acting muscarinic antagonist aclidinium

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valley TS, Sjoding MW, Ryan AM, Iwashyna TJ, Cooke CR. Association of intensive care unit admission with mortality among older patients with pneumonia. JAMA. doi:10.1001/jama.2015.11068.

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pham B, Stern A, Chen W, et al. Preventing pressure ulcers in long-term care: a costeffectiveness analysis. Arch Intern Med. Published online September 26, 2011. doi:10.1001/archinternmed.2011.473

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dodick DW, Silberstein SD, Bigal ME, et al. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. JAMA. doi:10.1001/jama.2018.4853

More information

Chapter 6: Medicare Expenditures for CKD

Chapter 6: Medicare Expenditures for CKD Chapter 6: Medicare Expenditures for CKD Introduction Determining the economic impact of chronic kidney disease (CKD) on the health care system is challenging on several levels. There is, for instance,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

Blood Pressure Monitoring in Chronic Kidney Disease

Blood Pressure Monitoring in Chronic Kidney Disease Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American

More information

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham

Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham Improvement Analytics Unit September 2018 Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham Therese Lloyd, Richard Brine, Rachel Pearson, Martin

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170(21):1909-1917. eappendix.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Nikolova AP, Hitzeman TC, Baum R, et al. Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection

More information

Predicting and changing the future for people with CKD

Predicting and changing the future for people with CKD Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Chen CL, Lin GA, Bardach NS, et al. Preoperative medical testing

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Western University Scholarship@Western Electronic Thesis and Dissertation Repository June 2015 Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Ngan Lam The University

More information

7-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs. Everolimus-Eluting Stents in Patients With Coronary Artery Disease (RESET)

7-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs. Everolimus-Eluting Stents in Patients With Coronary Artery Disease (RESET) 7-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs. Everolimus-Eluting Stents in Patients With Coronary Artery Disease (RESET) Hiroki Shiomi, MD Kyoto University Graduate School of Medicine

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rawshani Aidin, Rawshani Araz, Franzén S, et al. Risk factors,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information

Disclosures. CKD/ESRD care among vulnerable populations. Objectives. Case: Ms. S 3/12/2016. Delphine Tuot, MDCM, MAS Assistant Professor of Medicine

Disclosures. CKD/ESRD care among vulnerable populations. Objectives. Case: Ms. S 3/12/2016. Delphine Tuot, MDCM, MAS Assistant Professor of Medicine Disclosures CKD/ESRD care among vulnerable populations I have nothing to disclose Delphine Tuot, MDCM, MAS Assistant Professor of Medicine Objectives Recognize disparities related to kidney health Learn

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-Ethnic

More information

Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58

Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 Marc P. Bonaca MD MPH for the DECLARE TIMI 58 Investigators American College of Cardiology March 2019

More information

D:A:D: Cumulative Exposure to DRV/r Increase MI Risk

D:A:D: Cumulative Exposure to DRV/r Increase MI Risk D:A:D: Cumulative Exposure to DRV/r Increase MI Risk 20.0-15.0-10.0-5.0-4.0-3.0-2.0-1.0- Unadjusted CVD rate ratios per 5 years additional exposure: ATV/r 1.25 [1.10-1.43] and DRV/r 1.93 [1.63-2.28] Adjusted*

More information

Latency of potential treatment-related adverse events among patients treated with TKI/VEGF-directed therapy for metastatic renal cell carcinoma (mrcc)

Latency of potential treatment-related adverse events among patients treated with TKI/VEGF-directed therapy for metastatic renal cell carcinoma (mrcc) Latency of potential treatment-related adverse events among patients treated with TKI/VEGF-directed therapy for metastatic renal cell carcinoma (mrcc) Jun Gong, Daniel George, Herschel Wallen, Shivani

More information

Alexeeff et al. Environmental Health (2018) 17:38 https://doi.org/ /s

Alexeeff et al. Environmental Health (2018) 17:38 https://doi.org/ /s Alexeeff et al. Environmental Health (2018) 17:38 https://doi.org/10.1186/s12940-018-0382-1 RESEARCH High-resolution mapping of traffic related air pollution with Google street view cars and incidence

More information